Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy
In this study, a synthetic high-density lipoprotein (sHDL), peptide-based nanocarrier loaded with docetaxel (DTX) was constructed, against breast cancer. The thermodynamic and molecular dynamic analyses were conducted to examine the stability of nanoparticles synthesized from mimetic peptide 5 A and...
Saved in:
Main Authors: | Miaomiao Gong (Author), Qi Zhang (Author), Qi Zhao (Author), Jiani Zheng (Author), Yue Li (Author), Siling Wang (Author), Yue Yuan (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
by: Kuang-Yuh eChyu, et al.
Published: (2015) -
ApoA-I and Cancer
by: Maryam eZamanian-Daryoush, et al.
Published: (2015) -
Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
by: Wenqi Xu, et al.
Published: (2019) -
Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery
by: Xinyi Ma, et al.
Published: (2018) -
Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008)